Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Rahl PB"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brown JD; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN 37232; jonathan.d.brown@vanderbilt.edu jplutzky@bwh.harvard.edu james.bradner@novartis.com., Feldman ZB; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN 37232., Doherty SP; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN 37232., Reyes JM; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030., Rahl PB; Whitehead Institute for Biomedical Research, Cambridge, MA 02142., Lin CY; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030., Sheng Q; Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, TN 37232.; Department of Bioinformatics, Vanderbilt University School of Medicine, Nashville, TN 37232., Duan Q; Cardiovascular Division, Xiangya Hospital, Central South University, 410078 Changsha, Hunan, PR China., Federation AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115., Kung AL; Department of Pediatrics, Columbia University Medical Center, New York, NY 10032., Haldar SM; Gladstone Institute of Cardiovascular Disease and Department of Medicine, University of California, San Francisco, CA 94158., Young RA; Whitehead Institute for Biomedical Research, Cambridge, MA 02142.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139., Plutzky J; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115 jonathan.d.brown@vanderbilt.edu jplutzky@bwh.harvard.edu james.bradner@novartis.com., Bradner JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115; jonathan.d.brown@vanderbilt.edu jplutzky@bwh.harvard.edu james.bradner@novartis.com.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2018 Feb 27; Vol. 115 (9), pp. 2144-2149. Date of Electronic Publication: 2018 Feb 14.
Autor:
Kwiatkowski N; 1] Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA [2] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA [3] Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA [4]., Zhang T; 1] Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA [2] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA [3]., Rahl PB; Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA., Abraham BJ; Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA., Reddy J; 1] Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA [2] Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Ficarro SB; 1] Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA [2] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA [3] Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA., Dastur A; Department of Medicine Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts 02129, USA., Amzallag A; 1] Department of Medicine Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts 02129, USA [2] Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA., Ramaswamy S; 1] Department of Medicine Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts 02129, USA [2] Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA., Tesar B; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA [2] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA., Jenkins CE; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada., Hannett NM; Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA., McMillin D; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA [2] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA., Sanda T; 1] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA [2] Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore., Sim T; Chemical Kinomics Research Center, Korea Institute of Science and Technology, 39-1, Hawolgok-dong, Seongbuk-gu, Seoul 136-791, Korea, and KU-KIST Graduate School of Converging Science and Technology, 145, Anam-ro, Seongbuk-gu, Seoul 136-713, Korea., Kim ND; Daegu-Gyeongbuk Medical Innovation Foundation, 2387 dalgubeol-daero, Suseong-gu, Daegu 706-010, Korea., Look T; 1] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA [2] Division of Hematology/Oncology, Children's Hospital, Boston, Massachusetts 02115 USA., Mitsiades CS; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA [2] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA., Weng AP; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada., Brown JR; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA [2] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA., Benes CH; Department of Medicine Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts 02129, USA., Marto JA; 1] Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA [2] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA [3] Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA., Young RA; 1] Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA [2] Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Gray NS; 1] Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA [2] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Publikováno v:
Nature [Nature] 2014 Jul 31; Vol. 511 (7511), pp. 616-20. Date of Electronic Publication: 2014 Jun 22.
Autor:
Xiao S; Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Yosef N; Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Yang J; Tempero Pharmaceuticals (a GlaxoSmithKline company), Cambridge, MA 02139, USA., Wang Y; GlaxoSmithKline Research and Development Center, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China., Zhou L; GlaxoSmithKline Research and Development Center, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China., Zhu C; Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Wu C; Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Baloglu E; Tempero Pharmaceuticals (a GlaxoSmithKline company), Cambridge, MA 02139, USA., Schmidt D; Tempero Pharmaceuticals (a GlaxoSmithKline company), Cambridge, MA 02139, USA., Ramesh R; Tempero Pharmaceuticals (a GlaxoSmithKline company), Cambridge, MA 02139, USA., Lobera M; Tempero Pharmaceuticals (a GlaxoSmithKline company), Cambridge, MA 02139, USA., Sundrud MS; Tempero Pharmaceuticals (a GlaxoSmithKline company), Cambridge, MA 02139, USA., Tsai PY; Molecular and Cellular Immunology/Immune Regulation, DFG-Center for Regenerative Therapies Dresden, Technische Universität Dresden, Fetscherstrasse 105, 01307 Dresden, Germany., Xiang Z; GlaxoSmithKline Research and Development Center, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China., Wang J; GlaxoSmithKline Research and Development Center, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China., Xu Y; GlaxoSmithKline Research and Development Center, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China., Lin X; GlaxoSmithKline Research and Development Center, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China., Kretschmer K; Molecular and Cellular Immunology/Immune Regulation, DFG-Center for Regenerative Therapies Dresden, Technische Universität Dresden, Fetscherstrasse 105, 01307 Dresden, Germany., Rahl PB; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA., Young RA; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Zhong Z; GlaxoSmithKline Research and Development Center, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China., Hafler DA; Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT 06511, USA., Regev A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA., Ghosh S; Tempero Pharmaceuticals (a GlaxoSmithKline company), Cambridge, MA 02139, USA., Marson A; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA; Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address: alexander.marson@ucsf.edu., Kuchroo VK; Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: vkuchroo@rics.bwh.harvard.edu.
Publikováno v:
Immunity [Immunity] 2014 Apr 17; Vol. 40 (4), pp. 477-89.
Autor:
Anders L; 1] Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA. [2]., Guenther MG; 1] Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA. [2]., Qi J; Department of Medical Oncology, Dana-Farber Cancer Institute, Massachusetts, USA., Fan ZP; 1] Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA. [2] Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Marineau JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Massachusetts, USA., Rahl PB; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Lovén J; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Sigova AA; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Smith WB; Department of Medical Oncology, Dana-Farber Cancer Institute, Massachusetts, USA., Lee TI; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Bradner JE; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Massachusetts, USA. [2] Department of Medicine, Harvard Medical School, Massachusetts, USA., Young RA; 1] Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA. [2] Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2014 Jan; Vol. 32 (1), pp. 92-6. Date of Electronic Publication: 2013 Dec 15.
Autor:
Chapuy B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., McKeown MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Lin CY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Monti S; Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA 02118, USA., Roemer MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Qi J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Rahl PB; Whitehead Institute of Genome Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Sun HH; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Yeda KT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Doench JG; Broad Institute, Cambridge, MA 02142, USA., Reichert E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Kung AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Young RA; Whitehead Institute of Genome Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: margaret_shipp@dfci.harvard.edu., Bradner JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: james_bradner@dfci.harvard.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2013 Dec 09; Vol. 24 (6), pp. 777-90.
Autor:
Gurtan AM; David H. Koch Institute for Integrative Cancer Research, Cambridge, Massachusetts 02139, USA., Ravi A, Rahl PB, Bosson AD, JnBaptiste CK, Bhutkar A, Whittaker CA, Young RA, Sharp PA
Publikováno v:
Genes & development [Genes Dev] 2013 Apr 15; Vol. 27 (8), pp. 941-54.
Autor:
Whyte WA; Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA., Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA
Publikováno v:
Cell [Cell] 2013 Apr 11; Vol. 153 (2), pp. 307-19.